Physician profile
Mark Raymond Bagg
NPI 1730167479
$9,523.72
in general payments reported to CMS, 2019-2025
18 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $1,008 · 2021: $103 · 2022: $5,790 · 2023: $380 · 2024: $434 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $5,600.93 | 2022-2023 | Xiaflex |
| Medinc of Texas | $1,874.71 | 2019-2020 | |
| Arthrex, INC. | $397.74 | 2019 | |
| Acumed LLC | $356.08 | 2022-2024 | Innate Implant, Inframe Implant, Acumed |
| Depuy Synthes Sales INC. | $258.66 | 2022-2024 | Na |
| Skeletal Dynamics INC | $120.88 | 2022 | |
| Checkpoint Surgical, INC | $119.59 | 2023 | Checkpoint Stimulators |
| Arthrosurface Incorporated | $119.02 | 2025 | Wristmotion Wrist Hemiarthroplasty System |
| Pacira Therapeutics, INC. | $103.47 | 2021 | |
| Exsomed Corporation | $95.00 | 2020 | |
| Trice Medical, INC. | $92.27 | 2025 | |
| Smith+Nephew, INC. | $87.75 | 2019 | |
| Mission Medical Distribution, LLC | $77.70 | 2024-2025 | |
| Axogen | $64.50 | 2022-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Vertex Pharmaceuticals Incorporated | $59.07 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $42.28 | 2024 | I-Digits Quantum |
| Endo USA, INC. | $30.19 | 2025 | Xiaflex |
| Organogenesis INC. | $23.88 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bagg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.